Thorac Cardiovasc Surg 2020; 68(08): 687-694
DOI: 10.1055/s-0039-1677835
Original Cardiovascular

Off-pump Revascularization with Bilateral versus Single Mammary Arteries—A Propensity Score-Matched Analysis

Thomas Puehler
1   Klinik für Herz- und Gefäßchirurgie, Universitatsklinikum Schleswig-Holstein Campus Kiel, Kiel, Germany
,
Armin Zittermann
2   Department of Cardio-Thoracic Surgery, Heart Center NRW, Bad Oeynhausen, Germany
,
Mohamad Dia
3   Herzzentrum Duisburg, Duisburg, Nordrhein-Westfalen, Germany
,
Eric Emmel
2   Department of Cardio-Thoracic Surgery, Heart Center NRW, Bad Oeynhausen, Germany
,
Mustafa Gercek
3   Herzzentrum Duisburg, Duisburg, Nordrhein-Westfalen, Germany
,
Jochen Börgermann
3   Herzzentrum Duisburg, Duisburg, Nordrhein-Westfalen, Germany
,
Kavous Hakim-Meibodi
2   Department of Cardio-Thoracic Surgery, Heart Center NRW, Bad Oeynhausen, Germany
,
Jan Gummert
2   Department of Cardio-Thoracic Surgery, Heart Center NRW, Bad Oeynhausen, Germany
› Author Affiliations

Abstract

Background Coronary artery bypass grafting is the first-line therapy for severe multivessel coronary artery disease. We aimed to investigate the clinical outcome in patients undergoing isolated off-pump surgery with the single or bilateral internal mammary artery (SIMA or BIMA) approach.

Methods We performed a propensity score-matched analysis in 1,852 consecutive patients, aged 50 to 70 years, who underwent myocardial revascularization at our institution between July 2009 and August 2016. Primary end point was the probability of survival.

Results Mean follow-up was 36.3 (range: 0.1–89.6) months. The probability of survival in the SIMA and BIMA groups was 98.6 and 99.0% at year 1, 92.0 and 92.5% at year 5, and 85.6 and 81.6% at year 7, respectively, with a hazard ratio (HR) of mortality for the BIMA group versus the SIMA group of 0.98 (95% confidence interval[CI]: 0.64–1.52; p = 0.94). There was evidence for interaction between diabetes and study group on mortality risk (HR = 2.59, 95% CI: 1.07–6.23; p = 0.034). Freedom from mediastinitis/wound infection was higher in the SIMA group than in the BIMA group (99.5 and 96.9%, respectively; HR of an event = 6.39, 95% CI: 2.88–14.18; p < 0.001). The corresponding values in the subgroups of diabetic patients were 98.6 and 90.9%, respectively (HR = 6.45, 95% CI: 2.24–18.58; p = 0.001). Mediastinitis/wound infection was associated with increased mortality risk (HR = 2.96, 95% CI: 1.29–6.78; p = 0.010).

Conclusion Overall, our data indicate similar probability of survival up to a maximum follow-up of 7 years by off-pump surgery with the SIMA or BIMA approach. However, in diabetic patients, the clinical outcome indicates caution regarding the use of the BIMA approach.

Supplementary Material



Publication History

Received: 23 October 2018

Accepted: 19 December 2018

Article published online:
09 February 2019

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Windecker S, Kolh P, Alfonso F. et al; Authors/Task Force members. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014; 35 (37) 2541-2619
  • 2 Epstein AJ, Polsky D, Yang F, Yang L, Groeneveld PW. Coronary revascularization trends in the United States, 2001-2008. JAMA 2011; 305 (17) 1769-1776
  • 3 Palmerini T, Serruys P, Kappetein AP. et al. Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: a meta-analysis of 6 randomized trials and 4,686 patients. Am Heart J 2017; 190: 54-63
  • 4 Calafiore AM, Di Giammarco G, Teodori G. et al. Late results of first myocardial revascularization in multiple vessel disease: single versus bilateral internal mammary artery with or without saphenous vein grafts. Eur J Cardiothorac Surg 2004; 26 (03) 542-548
  • 5 Loop FD. Coronary artery surgery: the end of the beginning. Eur J Cardiothorac Surg 1998; 14 (06) 554-571
  • 6 Di Mauro M, Iacò AL, Acitelli A. et al. Bilateral internal mammary artery for multi-territory myocardial revascularization: long-term follow-up of pedicled versus skeletonized conduits. Eur J Cardiothorac Surg 2015; 47 (04) 698-702
  • 7 Buttar SN, Yan TD, Taggart DP, Tian DH. Long-term and short-term outcomes of using bilateral internal mammary artery grafting versus left internal mammary artery grafting: a meta-analysis. Heart 2017; 103 (18) 1419-1426
  • 8 Srivastava S, Gadasalli S, Agusala M. et al. Use of bilateral internal thoracic arteries in CABG through lateral thoracotomy with robotic assistance in 150 patients. Ann Thorac Surg 2006; 81 (03) 800-806 , discussion 806
  • 9 Yi G, Shine B, Rehman SM, Altman DG, Taggart DP. Effect of bilateral internal mammary artery grafts on long-term survival: a meta-analysis approach. Circulation 2014; 130 (07) 539-545
  • 10 Taggart DP, Altman DG, Gray AM. et al; ART Investigators. Effects of on-pump and off-pump surgery in the Arterial Revascularization Trial. Eur J Cardiothorac Surg 2015; 47 (06) 1059-1065
  • 11 Deo SV, Altarabsheh SE, Shah IK. et al. Are two really always better than one? Results, concerns and controversies in the use of bilateral internal thoracic arteries for coronary artery bypass grafting in the elderly: a systematic review and meta-analysis. Int J Surg 2015; 16 (Pt B): 163-170
  • 12 Emmert MY, Salzberg SP, Cetina Biefer HR. et al. Total arterial off-pump surgery provides excellent outcomes and does not compromise complete revascularization. Eur J Cardiothorac Surg 2012; 41 (04) e25-e31
  • 13 Raza S, Sabik III JF, Masabni K, Ainkaran P, Lytle BW, Blackstone EH. Surgical revascularization techniques that minimize surgical risk and maximize late survival after coronary artery bypass grafting in patients with diabetes mellitus. J Thorac Cardiovasc Surg 2014; 148 (04) 1257-1264 , discussion 1264–1266
  • 14 Dai C, Lu Z, Zhu H, Xue S, Lian F. Bilateral internal mammary artery grafting and risk of sternal wound infection: evidence from observational studies. Ann Thorac Surg 2013; 95 (06) 1938-1945
  • 15 Navia D, Vrancic M, Piccinini F. et al. Is the second internal thoracic artery better than the radial artery in total arterial off-pump coronary artery bypass grafting? A propensity score-matched follow-up study. J Thorac Cardiovasc Surg 2014; 147 (02) 632-638
  • 16 Deo SV, Shah IK, Dunlay SM. et al. Bilateral internal thoracic artery harvest and deep sternal wound infection in diabetic patients. Ann Thorac Surg 2013; 95 (03) 862-869
  • 17 Börgermann J, Hakim K, Renner A. et al. Clampless off-pump versus conventional coronary artery revascularization: a propensity score analysis of 788 patients. Circulation 2012; 126 (11) (Suppl. 01) S176-S182
  • 18 Fuchs U, Zittermann A, Stuettgen B, Groening A, Minami K, Koerfer R. Clinical outcome of patients with deep sternal wound infection managed by vacuum-assisted closure compared to conventional therapy with open packing: a retrospective analysis. Ann Thorac Surg 2005; 79 (02) 526-531
  • 19 Taggart DP, Altman DG, Gray AM. et al; ART Investigators. Randomized trial to compare bilateral vs. single internal mammary coronary artery bypass grafting: 1-year results of the Arterial Revascularisation Trial (ART). Eur Heart J 2010; 31 (20) 2470-2481
  • 20 Taggart DP, Altman DG, Gray AM. et al; ART Investigators. Randomized trial of bilateral versus single internal-thoracic-artery grafts. N Engl J Med 2016; 375 (26) 2540-2549
  • 21 DeSimone JP, Malenka DJ, Weldner PW. et al; Northern New England Cardiovascular Disease Study Group. Coronary revascularization with single versus bilateral mammary arteries: is it time to change?. Ann Thorac Surg 2018; 106 (02) 466-472
  • 22 Locker C, Schaff HV, Dearani JA. et al. Multiple arterial grafts improve late survival of patients undergoing coronary artery bypass graft surgery: analysis of 8622 patients with multivessel disease. Circulation 2012; 126 (09) 1023-1030
  • 23 Iribarne A, Westbrook BM, Malenka DJ. et al; Northern New England Cardiovascular Disease Study Group. Should diabetes be a contraindication to bilateral internal mammary artery grafting?. Ann Thorac Surg 2018; 105 (03) 709-714
  • 24 Sá MP, Cavalcanti PE, de Andrade Costa Santos HJ. et al. Skeletonized versus pedicled bilateral internal mammary artery grafting: outcomes and concerns analyzed through a meta-analytical approach. Int J Surg 2015; 16 (Pt B): 146-152
  • 25 Benedetto U, Altman DG, Gerry S. et al; Arterial Revascularization Trial investigators. Pedicled and skeletonized single and bilateral internal thoracic artery grafts and the incidence of sternal wound complications: Insights from the Arterial Revascularization Trial. J Thorac Cardiovasc Surg 2016; 152 (01) 270-276
  • 26 Raja SG. Bilateral internal mammary artery grafting in diabetics: outcomes, concerns and controversies. Int J Surg 2015; 16 (Pt B): 153-157
  • 27 Martin ET, Kaye KS, Knott C. et al. Diabetes and risk of surgical site infection: a systematic review and meta-analysis. Infect Control Hosp Epidemiol 2016; 37 (01) 88-99